Zolgensma, Novartis' gene therapy for SMA, remains the world's most expensive medicine, priced between $1.2 million and $2.1 million per dose. Despite its high cost, it's...
The Spanish company Marsi Bionics will use the funds to develop its pediatric products on an industrial scale and prepare them for the international market. Currently,...